ICON plc is a clinical research organization (CRO) that provides outsourced clinical, consulting, and commercial services to pharmaceutical, biotechnology, medical device, and government organizations. The company assists clients with drug development, clinical trials, laboratory services, regulatory affairs, and market access strategies.
Subscribe to see ICON PLC EO-,06’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ICON PLC EO-,06 is a pharmaceutical services company headquartered in Dublin, Ireland. Xcout tracks 4 named people at ICON PLC EO-,06, including Deepali Suri (President of ICON Biotech).
A few of ICON PLC EO-,06's closest competitors — see the full list of competitors and alternatives →
Syneos Health is a biopharmaceutical solutions organization and contract research organization (CRO) that provides clinical development, regulatory, safety, and commercialization services. It serves biopharmaceutical and life sciences companies by offering clinical trials, consulting, marketing, and deployment solutions to help bring therapies to market.
PPD is a global contract research organization (CRO) providing comprehensive clinical development, laboratory, and functional service partnership solutions for the pharmaceutical and biotech industries.
Parexel is a contract research organization (CRO) that provides comprehensive biopharmaceutical services to the life sciences industry. The company offers end-to-end solutions spanning portfolio optimization, regulatory strategy, Phase I-IV clinical trials, market access planning, and post-approval lifecycle management.
Clinigen is a global pharmaceutical services company that helps healthcare providers and pharmaceutical companies access, supply, and distribute medicines, including unlicensed and specialty medicines. It also supports clinical-trial supply and post-approval commercialization of pharmaceutical products.
PCI Pharma Services is a global contract development and manufacturing organization (CDMO) that supports biopharmaceutical clients in bringing drug products to market.
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about ICON PLC EO-,06? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.